Chimerix (NASDAQ:CMRX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Chimerix (NASDAQ:CMRX – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. CMRX has been the subject of a number of other research reports. HC Wainwright restated a “neutral” rating and set a […]
StockNews.com started coverage on shares of Chimerix (NASDAQ:CMRX – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. CMRX has been the subject of a number of other research reports. HC Wainwright restated a “neutral” rating and set a […]
